Trial of Epinephrine and Albuterol in Bronchiolitis
Status:
Unknown status
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see which of the two most common drugs used to treat
bronchiolitis works better. A child's participation in this study is expected to last less
than 4 hours. Approximately 600 patients will be recruited to participate in this study at
Kern Medical Center (KMC).
Bronchiolitis is a very common lung infection in babies. There are many drugs used to treat
this disease but nobody knows which one, if any, works the best. Two of the most commonly
used drugs are albuterol and epinephrine. These are both drugs given during breathing
treatments with oxygen and a mask. We are doing this study to see which of these drugs works
better or if they are both equally good. The study works as follows: after the consent
process the baby gets three treatments.
- Nebulizer 1 (Treatment)
- Treatment + 30 minutes (approximately) Nebulizer 2
- Treatment + 60 minutes (approximately) Nebulizer 3
- Treatment + 120 minutes (approximately)
The baby will be reevaluated and either discharged home or revert to standard therapy. If the
baby is discharged directly from the emergency department (E.D.), we will call you in three
days time to see how he/she is doing.